Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 14 2 2019
medline: 14 2 2019
entrez: 14 2 2019
Statut: ppublish

Résumé

The 'Competing interests' statement of this Article has been updated; please see the accompanying Amendment. The original Article has not been corrected online.

Identifiants

pubmed: 30755741
doi: 10.1038/s41586-019-0974-0
pii: 10.1038/s41586-019-0974-0
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

E11-E12

Commentaires et corrections

Type : ErratumFor

Auteurs

David M Hyman (DM)

Memorial Sloan Kettering Cancer Center, New York, New York, USA. hymand@mskcc.org.

Sarina A Piha-Paul (SA)

University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

Helen Won (H)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Jordi Rodon (J)

Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Cristina Saura (C)

Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Geoffrey I Shapiro (GI)

Dana-Faber Cancer Institute, Boston, Massachusetts, USA.

Dejan Juric (D)

Massachusetts Hospital Cancer Center, Boston, Massachusetts, USA.

David I Quinn (DI)

USC Norris Comprehensive Cancer Center, Los Angeles, California, USA.

Victor Moreno (V)

START Madrid Fundación Jímenez Díaz, Madrid, Spain.

Bernard Doger (B)

START Madrid Fundación Jímenez Díaz, Madrid, Spain.

Ingrid A Mayer (IA)

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.

Valentina Boni (V)

START Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain.

Emiliano Calvo (E)

START Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain.

Sherene Loi (S)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Albert C Lockhart (AC)

Washington University in St. Louis School of Medicine, St Louis, Missouri, USA.

Joseph P Erinjeri (JP)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Maurizio Scaltriti (M)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Gary A Ulaner (GA)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Juber Patel (J)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Jiabin Tang (J)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Hannah Beer (H)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

S Duygu Selcuklu (SD)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Aphrothiti J Hanrahan (AJ)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Nancy Bouvier (N)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Myra Melcer (M)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Rajmohan Murali (R)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Alison M Schram (AM)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Lillian M Smyth (LM)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Komal Jhaveri (K)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Bob T Li (BT)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Alexander Drilon (A)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

James J Harding (JJ)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Gopa Iyer (G)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Barry S Taylor (BS)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Michael F Berger (MF)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Richard E Cutler (RE)

Puma Biotechnology Inc., Los Angeles, California, USA.

Feng Xu (F)

Puma Biotechnology Inc., Los Angeles, California, USA.

Anna Butturini (A)

Puma Biotechnology Inc., Los Angeles, California, USA.

Lisa D Eli (LD)

Puma Biotechnology Inc., Los Angeles, California, USA.

Grace Mann (G)

Puma Biotechnology Inc., Los Angeles, California, USA.

Cynthia Farrell (C)

Puma Biotechnology Inc., Los Angeles, California, USA.

Alshad S Lalani (AS)

Puma Biotechnology Inc., Los Angeles, California, USA.

Richard P Bryce (RP)

Puma Biotechnology Inc., Los Angeles, California, USA.

Carlos L Arteaga (CL)

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.

Funda Meric-Bernstam (F)

University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

José Baselga (J)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

David B Solit (DB)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Classifications MeSH